Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

4 Stocks To Watch Today: CBAY, CONN, LITE, NTNX

Published 10/26/2017, 01:12 AM
Updated 07/09/2023, 06:31 AM

Cymabay Therapeu (NASDAQ:CBAY), an old swing of ours, is acting well. From the breakout and base, the pullback, and then the breakout in May, this stock has been moving up steadily, and it formed a wedge. It has a mid-channel line, and the recent pullback was taken out on Tuesday, as the volume thrust to 1.3 million shares traded, popping 85 cents, or 11%, to 8.73. It looks like that if it takes out the recent highs, it could run up to 10, 11 3/4, even as high as the 13-4 zone over the next week.

Conns Inc (NASDAQ:CONN), a retail stock, has been phenomenal since the March low when it was trading under 8 dollars. On Tuesday, it jumped 4.45, or 17%, to 31.30, on 2.4 million shares traded, the high 32.00, now up four-fold. That’s the biggest volume since April-May. I’m thinking this may accelerate to the top of the channel, and then make a move to the low 40’s. So, my two targets are 35, and 41-2 going forward. It has 10 days to cover , and I think the shorts are on a squeeze here.

Lumentum Holdings Inc (NASDAQ:LITE) has a very strong channel and a very strong pattern. It broke out of a base on Tuesday that took a couple months to develop, and popped 3.60, or 6%, to 63.10, on 3.7 million shares traded. That’s the biggest volume in about 8-9 weeks. There is resistance overhead at about the 65-range. If it gets through that, the target is 68-9.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Nutanix Inc (NASDAQ:NTNX) is acting great. Looking at the chart from Tuesday, most importantly, it looks like it came out through a double top after going back two days ago. That consolidation above the key level is where it broke out, jumping 1.49, or 5.63%, to 27.95. With the volume at 5.6 million shares traded and 5 days to cover , it looks like 30-1, and then 33-4 are coming soon.

On the long side, stocks included Cymabay Therapeutics, Inc. (CBAY), Concert Pharmaceuticals, Inc. (CNCE), Conns Inc. (CONN), Majesco Entertainment Company (COOL), General Motors Company (NYSE:GM), Lumentum Holdings Inc. (LITE), NeoPhotonics Corporation (NPTN), NUTANIX, INC. (NTNX), Overstock.com, Inc. (NASDAQ:OSTK), Polaris Industries Inc (NYSE:PII), Fang Holdings Limited (SFUN), Social Reality, Inc. (SRAX), Tailored Brands, Inc. (TLRD), Volt Information Sciences, Inc. (VISI), and Xunlei Ltd Adr (NASDAQ:XNET).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.